Former Executive Chairman of the Board · Avalo Therapeutics, Inc. (AVTX)

Simon Pedder

A named executive officer of Avalo Therapeutics in every fiscal year CompBrief holds from FY2018 to FY2019. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2019

$3,776,649

Salary $247,917Stock awards $1,245,000Bonus $157,500

FY2018: $27,644

1st of 4 named executive officers at Avalo Therapeutics by FY2019 total.

4 named officers on file for Avalo Therapeutics, FY2019

Simon Pedder’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Avalo Therapeutics’s whole pay program stands against its peers

  • Avalo Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AVTX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2020 (DEF 14A).

Free

Get Simon Pedder’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Simon Pedder compensation by year

Avalo Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Avalo Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019
Salary$0$247,917
Bonus$0$157,500
Stock awards$0$1,245,000
Option awards$0$1,855,965
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$27,644$270,267
Total$27,644$3,776,649

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Avalo Therapeutics, Inc. DEF 14A filed April 28, 2020, accession 0001628280-20-005735, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Avalo Therapeutics, Inc. filed document, accession 0001628280-20-005735. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2020.

$28K
$3.8M
FY18
FY19
SalaryBonusStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
Option11,143—$4.14
Option300,000—$5.17
Option300,000—$4.98
RSU200,000——

Per the Outstanding Equity Awards at Fiscal Year-End table in Avalo Therapeutics, Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Avalo Therapeutics’s named executive officers, FY2019

as the company reported each
Named executive officerRoleFY2019 total
Simon Pedder · this pageFormer Executive Chairman of the Board$3,776,649
Pericles CaliasFormer Chief Scientific Officer$1,345,362
Joseph MillerChief Financial Officer and Principal Financial Officer$1,170,598
Peter GreenleafFormer Chief Executive Officer and former Principal Executive Officer$735,204

The full Avalo Therapeutics compensation record

free company brief

This page is one person within Avalo Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Avalo Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Simon Pedder's compensation dossier · One-time report. No refunds.